Aspira Pathlab & Diagnostics Ltd's Stock Reaches 52-Week High, Outperforms Sector
Aspira Pathlab & Diagnostics Ltd, a microcap company in the hospital and healthcare services industry, has seen a surge in its stock price, reaching a 52-week high of Rs.57.3 on November 4th, 2024. The stock has outperformed the sector and is currently trading above its moving averages, indicating a positive trend. Its strong performance over the past year has also surpassed the Sensex's performance.
Aspira Pathlab & Diagnostics Ltd, a microcap company in the hospital and healthcare services industry, has recently seen a surge in its stock price. On November 4th, 2024, the company's stock reached a 52-week high of Rs.57.3. This has caught the attention of investors and market analysts, with MarketsMOJO giving a 'Sell' call for the stock.
In today's trading, Aspira Pathlab's stock has outperformed the sector by 1.94%. This is a continuation of its recent upward trend, as the stock has been gaining for the past four days and has seen a 12.09% increase in returns during this period. Additionally, the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend.
In comparison to the Sensex, Aspira Pathlab has shown a strong performance over the past year, with a 48.94% increase in its stock price. This is significantly higher than the Sensex's performance of 22.76% during the same period.
Aspira Pathlab & Diagnostics Ltd's recent surge in stock price is a reflection of its strong performance in the hospital and healthcare services industry. With its stock trading at a 52-week high and outperforming the sector, the company is poised for continued growth and success in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
